AAAAAA

   
Results: 1-11 |
Results: 11
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
Authors: Smith, MR McGovern, FJ Zietman, AL Fallon, MA Hayden, DL Schoenfeld, DA Kantoff, PW Finkelstein, JS
Citation: Mr. Smith et al., Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer., N ENG J MED, 345(13), 2001, pp. 948-955
Metabolism of orally administered androstenedione in young men
Authors: Leder, BZ Catlin, DH Longcope, C Ahrens, B Schoenfeld, DA Finkelstein, JS
Citation: Bz. Leder et al., Metabolism of orally administered androstenedione in young men, J CLIN END, 86(8), 2001, pp. 3654-3658
Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome
Authors: Fairfield, WP Finkelstein, JS Klibanski, A Grinspoon, SK
Citation: Wp. Fairfield et al., Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome, J CLIN END, 86(5), 2001, pp. 2020-2026
Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men
Authors: Leder, BZ Smith, MR Fallon, MA Lee, MLT Finkelstein, JS
Citation: Bz. Leder et al., Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men, J CLIN END, 86(2), 2001, pp. 511-516
Low bone mineral density in hormone-naive men with prostate carcinoma
Authors: Smith, MR McGovern, FJ Fallon, MA Schoenfeld, D Kantoff, PW Finkelstein, JS
Citation: Mr. Smith et al., Low bone mineral density in hormone-naive men with prostate carcinoma, CANCER, 91(12), 2001, pp. 2238-2245
Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men
Authors: Zmuda, JM Cauley, JA Glynn, NW Finkelstein, JS
Citation: Jm. Zmuda et al., Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men, J BONE MIN, 15(7), 2000, pp. 1417-1424
Trace contamination of over-the-counter androstenedione and positive urinetest results for a nandrolone metabolite
Authors: Catlin, DH Leder, BZ Ahrens, B Starcevic, B Hatton, CK Green, GA Finkelstein, JS
Citation: Dh. Catlin et al., Trace contamination of over-the-counter androstenedione and positive urinetest results for a nandrolone metabolite, J AM MED A, 284(20), 2000, pp. 2618-2621
Oral androstenedione administration and serum testosterone concentrations in young men
Authors: Leder, BZ Longcope, C Catlin, DH Ahrens, B Schoenfeld, DA Finkelstein, JS
Citation: Bz. Leder et al., Oral androstenedione administration and serum testosterone concentrations in young men, J AM MED A, 283(6), 2000, pp. 779-782
Relative eosinophilia (Thorn test) as a bioassay to judge the clinical relevance of cortisol values during severe stress
Authors: Finkelstein, JS Klibanski, A Neer, RM
Citation: Js. Finkelstein et al., Relative eosinophilia (Thorn test) as a bioassay to judge the clinical relevance of cortisol values during severe stress, J CLIN END, 84(9), 1999, pp. 3400-3401
Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women
Authors: Finkelstein, JS Schoenfeld, DA
Citation: Js. Finkelstein et Da. Schoenfeld, Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women, J CLIN END, 84(6), 1999, pp. 2151-2156
Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis
Authors: Finkelstein, JS Arnold, AL
Citation: Js. Finkelstein et Al. Arnold, Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis, J CLIN END, 84(4), 1999, pp. 1214-1219
Risultati: 1-11 |